AlfaSigma (ex Alfa Wassermann and Sigma Tau) has been a leader in the Italian pharmaceutical industry since 1940. AlfaSigma is the largest Italian company operating in Tunisia’s pharmaceutical sector with three products generating 98 percent of its revenues. The affiliate is now looking forward to integrating Sigma Tau’s products to its portfolio to continue growing in Tunisia.
Contact:
Jade Salhab, senior private sector development specialist at World Bank Tunisia, discusses the impact of the public-private dialogues initiated by his organization in Tunisia, and the additional measures needed to…
Hamouda Zaouia, regional manager Africa, Middle East and Turkey, and Khaled Laouiti, general manager Tunisia, Libya and sub-Saharan Africa, stress the important strategic position the African continent has for Pierre…
Salim Ouertani, business unit manager at AbbVie Tunisia, has been with the affiliate since its beginning in Tunisia when it was spun-off from Abbott in 2013, being in charge of…
Fabrice Barbu, general manager of Servier Tunisia, discusses how Servier wants to build a strong presence in the oncology field in Tunisia and is currently investigating the possibilities of bringing…
Mohamed Khalil Tamim, Alcon’s head of regulatory affairs Africa manages the regulatory affairs of 47 countries in Alcon’s African cluster. He explains the necessity of creating and harmonizing medical device-specific…
Alya El Hedda, GM of Opalia-Recordati in Tunisia, describes the Opalia affiliate’s evolution since the Recordati takeover, her ambitions for the future, and how the company will leverage its production…
Slim Chouchane, general director of Alfasigma in Tunisia, discusses the integration with Sigma Tau, the Italian company acquired by Alfa Wassermann in 2016, Chouchane retraces the incredible success of Alfa…
Chokri Jeribi, country chair of Sanofi Tunisia since 2016, is responsible for the development and market leadership hold of Sanofi’s affiliate in Tunisia. In this interview he stresses the importance…
Fatma Thabet Chiboub, CEO of the Bizerta Economic Activities Park (PAEB) in Tunisia, explains the advantages for a company of establishing itself in the PAEB, the importance of high added-value…
Jean-François Courtet, who has been leading the Tunisian affiliate of Novo Nordisk as general manager for three years, discusses the prevalence of diabetes and lack of awareness thereof in Tunisia,…
Jean-François Courtet, who has been leading the Tunisian affiliate of Novo Nordisk as general manager for three years, discusses the prevalence of diabetes and lack of awareness thereof in Tunisia,…
Riadh Daghfous, managing director of the Tunisian National Pharmacovigilance Center (CNPV), describes the role of the CNPV in side-effect monitoring, pharmacovigilance, and marketing authorizations. CNPV plays a central role in…
See our Cookie Privacy Policy Here
